<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="inlinetable1" position="anchor"><table frame="hsides" rules="groups"><thead><tr valign="top"><th><break/></th><th>Min</th><th>1<sup>st</sup> QU</th><th>Median</th><th>Mean</th><th>3<sup>rd</sup> QU</th><th>Max</th></tr></thead><tbody><tr><td colspan="7" valign="top">PEF (% predicted)</td></tr><tr valign="top"><td>Healthy group before viral challenge</td><td>63.31</td><td>84.63</td><td>91.52</td><td>92.16</td><td>100.97</td><td>119.01</td></tr><tr valign="top"><td>Healthy group after viral challenge</td><td>63.42</td><td>78.42</td><td>91.92</td><td>90.44</td><td>102.39</td><td>118.84</td></tr><tr valign="top"><td>Asthmatics group before viral challenge</td><td>57.62</td><td>82.45</td><td>88.64</td><td>86.77</td><td>94.14</td><td>105.09</td></tr><tr valign="top"><td>Asthmatics group after viral challenge</td><td>47.67</td><td>78.49</td><td>88.44</td><td>85.01</td><td>95.21</td><td>109.98</td></tr><tr><td colspan="7" valign="top">Normalized FEV1</td></tr><tr valign="top"><td>Healthy group before viral challenge</td><td>-2.7287</td><td>-1.5404</td><td>-0.9138</td><td>-1.0405</td><td>-0.7148</td><td>0.3588</td></tr><tr valign="top"><td>Healthy group after viral challenge</td><td>-3.0971</td><td>-1.9662</td><td>-1.3308</td><td>-1.3310</td><td>-0.8425</td><td>0.4305</td></tr><tr valign="top"><td>Asthmatics group before viral challenge</td><td>-2.4603</td><td>-2.1253</td><td>-1.0570</td><td>-1.3044</td><td>-0.8828</td><td>-0.1823</td></tr><tr valign="top"><td>Asthmatics group after viral challenge</td><td>-3.0350</td><td>-2.1484</td><td>-1.1480</td><td>-1.3369</td><td>-0.8418</td><td>0.5686</td></tr><tr><td colspan="7" valign="top">Normalized FVC</td></tr><tr valign="top"><td>Healthy group before viral challenge</td><td>-2.19123</td><td>-1.87550</td><td>-1.66646</td><td>-1.34813</td><td>-0.83674</td><td>-0.02098</td></tr><tr valign="top"><td>Healthy group after viral challenge</td><td>-3.0841</td><td>-2.6730</td><td>-2.1174</td><td>-1.7966</td><td>-0.9592</td><td>0.2229</td></tr><tr valign="top"><td>Asthmatics group before viral challenge</td><td>-3.0841</td><td>-2.6730</td><td>-2.1174</td><td>-1.7966</td><td>-0.9592</td><td>0.2229</td></tr><tr valign="top"><td>Asthmatics group after viral challenge</td><td>-3.726</td><td>-1.840</td><td>-1.319</td><td>-1.483</td><td>-0.668</td><td>0.194</td></tr><tr><td colspan="7" valign="top">Normalized FEV1/FVC</td></tr><tr valign="top"><td>Healthy group before viral challenge</td><td>-1.4796</td><td>0.1851</td><td>0.6670</td><td>0.6940</td><td>1.3305</td><td>2.1131</td></tr><tr valign="top"><td>Healthy group after viral challenge</td><td>-0.6591</td><td>0.1088</td><td>1.3446</td><td>1.1083</td><td>1.9541</td><td>2.5255</td></tr><tr valign="top"><td>Asthmatics group before viral challenge</td><td>-1.2123</td><td>-0.5753</td><td>-0.3160</td><td>0.1677</td><td>1.2150</td><td>1.7450</td></tr><tr valign="top"><td>Asthmatics group after viral challenge</td><td>-1.5441</td><td>-0.4089</td><td>0.3237</td><td>0.4484</td><td>1.3195</td><td>2.5751</td></tr><tr><td colspan="7" valign="top">FeNO</td></tr><tr valign="top"><td>Healthy group before viral challenge</td><td>9.435</td><td>12.779</td><td>13.872</td><td>14.608</td><td>15.594</td><td>22.227</td></tr><tr valign="top"><td>Healthy group after viral challenge</td><td>7.545</td><td>10.807</td><td>16.143</td><td>15.841</td><td>19.350</td><td>25.909</td></tr><tr valign="top"><td>Asthmatics group before viral challenge</td><td>16.57</td><td>35.67</td><td>46.21</td><td>61.97</td><td>55.68</td><td>181.30</td></tr><tr valign="top"><td>Asthmatics group after viral challenge</td><td>18.36</td><td>29.80</td><td>42.59</td><td>61.42</td><td>58.73</td><td>181.18</td></tr><tr><td colspan="7" valign="top">Cell density in 10<sup>6</sup> per ml of nasal lavage fluid</td></tr><tr valign="top"><td>Healthy group before viral challenge</td><td>0.1975</td><td>0.4308</td><td>0.5569</td><td>0.9327</td><td>1.2431</td><td>2.4600</td></tr><tr valign="top"><td>Healthy group after viral challenge</td><td>0.3436</td><td>0.6409</td><td>1.4536</td><td>1.6078</td><td>2.3982</td><td>3.7255</td></tr><tr valign="top"><td>Asthmatics group before viral challenge</td><td>0.0375</td><td>0.2490</td><td>0.8489</td><td>1.4183</td><td>1.8562</td><td>5.0444</td></tr><tr valign="top"><td>Asthmatics group after viral challenge</td><td>0.2873</td><td>0.9698</td><td>1.8445</td><td>2.7841</td><td>4.0850</td><td>10.8618</td></tr><tr><td colspan="7" valign="top">Percentage of Eosinophils in nasal lavage fluid</td></tr><tr valign="top"><td>Healthy group before viral challenge</td><td>0.00000</td><td>0.00000</td><td>0.04375</td><td>0.95683</td><td>0.36979</td><td>9.03750</td></tr><tr valign="top"><td>Healthy group after viral challenge</td><td>0.0000</td><td>0.0000</td><td>0.0500</td><td>1.2977</td><td>0.2909</td><td>14.1273</td></tr><tr valign="top"><td>Asthmatics group before viral challenge</td><td>0.4091</td><td>7.2031</td><td>14.3950</td><td>16.9439</td><td>28.9778</td><td>35.9111</td></tr><tr valign="top"><td>Asthmatics group after viral challenge</td><td>0.000</td><td>7.218</td><td>10.227</td><td>13.186</td><td>13.935</td><td>59.736</td></tr><tr><td colspan="7" valign="top">Percentage of Neutrophils in nasal lavage fluid</td></tr><tr valign="top"><td>Healthy group before viral challenge</td><td>24.90</td><td>47.36</td><td>58.90</td><td>62.45</td><td>86.44</td><td>99.64</td></tr><tr valign="top"><td>Healthy group after viral challenge</td><td>18.18</td><td>51.45</td><td>66.16</td><td>61.72</td><td>72.33</td><td>88.95</td></tr><tr valign="top"><td>Asthmatics group before viral challenge</td><td>29.30</td><td>36.18</td><td>60.47</td><td>57.23</td><td>79.79</td><td>92.72</td></tr><tr valign="top"><td>Asthmatics group after viral challenge</td><td>27.53</td><td>55.17</td><td>68.01</td><td>66.96</td><td>80.31</td><td>97.29</td></tr></tbody></table></table-wrap>